MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Aberrant expression of microRNAs (miRNAs) plays important roles in carcinogenesis and tumor progression. However, the expression and biological role of miR-301b in triple-negative breast cancer (TNBC) remains unclear. Here we aimed to evaluate the roles and mechanisms of miR-301b in TNBC cells. miR-301b expression was assessed in TNBC specimens and cell lines by quantitative Real-Time PCR (qRT-PCR). TNBC cells were transfected with miR-301b mimics, inhibitors or Cylindromatosis (CYLD) small interfering RNA (siRNA) using Lipofectamine 2000. The functional roles of miR-301b were determined by cell proliferation, colony formation, and apoptosis assays. Western blots and qRT-PCR were used to measure the expression of mRNAs and proteins in the cells. We found that miR-301b was upregulated in TNBC specimens and cell lines. Overexpression of miR-301b promoted cell proliferation in TNBC cells, while inhibited the apoptosis induced by 5-FU. CYLD was downregulated by miR-301b at both mRNA and protein levels in TNBC cells. Dual-luciferase report assay confirmed that miR-301b downregulated CYLD by direct interaction with the 3’-untranslated region(3’-UTR) of CYLD mRNA. NF-B activation was mechanistically associated with miR-301b-mediated downregulation of CYLD. However, inhibition of miR-301b reversed all the effects of miR-301b. In conclusion, miR-301b plays an oncogenic role in TNBC possibly by downregulating CYLD and subsequently activating NF-B p65, and this may provide a novel therapeutic approach for TNBC.
Abstract
Aberrant expression of microRNAs (miRNAs) plays important roles in carcinogenesis and tumor progression. However, the expression and biological role of miR-301b in triple-negative breast cancer (TNBC) remains unclear. Here we aimed to evaluate the roles and mechanisms of miR-301b in TNBC cells. miR-301b expression was assessed in TNBC specimens and cell lines by quantitative Real-Time PCR (qRT-PCR). TNBC cells were transfected with miR-301b mimics, inhibitors or Cylindromatosis (CYLD) small interfering RNA (siRNA) using Lipofectamine 2000. The functional roles of miR-301b were determined by cell proliferation, colony formation, and apoptosis assays. Western blots and qRT-PCR were used to measure the expression of mRNAs and proteins in the cells. We found that miR-301b was upregulated in TNBC specimens and cell lines. Overexpression of miR-301b promoted cell proliferation in TNBC cells, while inhibited the apoptosis induced by 5-FU. CYLD was downregulated by miR-301b at both mRNA and protein levels in TNBC cells. Dual-luciferase report assay confirmed that miR-301b downregulated CYLD by direct interaction with the 3’-untranslated region(3’-UTR) of CYLD mRNA. NF-B activation was mechanistically associated with miR-301b-mediated downregulation of CYLD. However, inhibition of miR-301b reversed all the effects of miR-301b. In conclusion, miR-301b plays an oncogenic role in TNBC possibly by downregulating CYLD and subsequently activating NF-B p65, and this may provide a novel therapeutic approach for TNBC.
참고문헌 (26)
- Dawood S, "Triple-negative breast cancer: epidemiology and management options", Drugs, 70, pp.2247~2258 (2010)
- Lee A, "Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies", Cancer Treat Rev, 62, pp.110~122 (2018)
- Fkih M'hamed I, "miR-10b, miR-26a, miR-146a and miR-153 expression in triple negative vs non triple negative breast cancer: Potential biomarkers", Pathol Oncol Res, 23, pp.815~827 (2017)
- Griffiths-Jones S, "miRBase: microRNA sequences, targets and gene nomenclature", Nucleic Acids Res, 34, pp.D140~D144 (2006)
- Ardekani AM, "The role of microRNAs in human diseases", Avicenna J Med Biotechnol, 2, pp.161~179 (2010)
- Tufekci KU, "The role of microRNAs in biological processes", Methods Mol Biol, 1107, pp.15~31 (2014)
- Calin GA, "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers", Proc Natl Acad Sci U S A, 101, pp.2999~3004 (2004)
- Wu D, "Hypoxia-induced microRNA-301b regulates apoptosis by targeting Bim in lung cancer", Cell Prolif, 49, pp.476~483 (2016)
- Funamizu N, "MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells", Int J Oncol, 44, pp.725~734 (2014)
- B activity, "Annu Rev Immunol", 2000, 621~663
- Li Q, "NF-kappaB regulation in the immune system", Nat Rev Immunol, 2, pp.725~734 (2002)
- Yamaguchi N, "Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines", Cancer Sci, 100, pp.1668~1674 (2009)
- Biswas DK, "NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis", Proc Natl Acad Sci U S A, 101, pp.10137~10142 (2004)
- Sovak MA, "Aberrant nuclear factor-kappaB", Rel expression and the pathogenesis of breast cancer, 1997, pp.100, 2952~2960
- Zhou Y, "Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers", Int J Biochem Cell Biol, 37, pp.1130~1144 (2005)
- Kovalenko A, "The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination", Nature, 424, pp.801~805 (2003)
- Brummelkamp TR, "Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB", Nature, 424, pp.797~801 (2003)
- Trompouki E, "CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members", Nature, 424, pp.793~796 (2003)
- Hayashi M, "Clinical significance of CYLD downregulation in breast cancer", Breast Cancer Res Treat, 143, pp.447~457 (2014)
- Liu M, "The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion", Cancer Res, 70, pp.10464~10473 (2010)
- Wang YX, "Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis", J Dig Dis, 11, pp.50~54 (2010)
- Sun SC, "CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes", Cell Death Differ, 17, pp.25~34 (2010)
- Hellerbrand C, "Reduced expression of CYLD in human colon and hepatocellular carcinomas", Carcinogenesis, 28, pp.21~27 (2007)
- Wang L, "The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene", Mol Cell Biol, 25, pp.7953~7965 (2005)
- Massoumi R, "Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma", J Exp Med, 206, pp.221~232 (2009)
- Song HM, "Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt", FOXO1, Onco Targets Ther, pp.2015, 8[DOI]